Trial Outcomes & Findings for Clinical Evaluation of Investigational Contact Lenses (NCT NCT02801396)

NCT ID: NCT02801396

Last Updated: 2017-07-11

Results Overview

CLUE Handling is assessed using the Contact Lens User Experience (CLUE™) Questionnaire. CLUE™ is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact lens-wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable / positive response. 97% of the scores fall within 0 and 120 (mean +/- 3XSD).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

116 participants

Primary outcome timeframe

30 Minutes Post Insertion

Results posted on

2017-07-11

Participant Flow

A total of 116 subjects were enrolled into the study. Of the enrolled subjects 15 were not dispensed a study lens. A total of 101 subjects were dispensed a study lens. Of the dispensed subjects 1 was discontinued and 100 subjects completed the study.

Participant milestones

Participant milestones
Measure
Test1/Test2/Control
Subjects that received Test lens 1 during the first period, Test lens 2 during the second period and the Control lens during the third period.
Test1/Control/Test2
Subjects that received Test lens 1 during the first period, the Control lens during the second period and Test lens 2 during the third period.
Test2/Test1/Control
Subjects that received Test lens 2 during the first period, Test lens 1 during the second period and the Control lens during the third period.
Test2/Control/Test1
Subjects that received Test lens 2 during the first period, the Control lens during the second and the Test 1 lens during the third period.
Control/Test1/Test2
Subjects that received the Control lens during the first period, Test lens 1 during the second period and Test lens 2 during the third period.
Control/Test2/Test1
Subjects that received the Control lens during the first period, Test 2 lens during the second period and Test lens 1 during the third period.
Period 1
STARTED
17
17
17
16
17
17
Period 1
COMPLETED
17
17
17
16
16
17
Period 1
NOT COMPLETED
0
0
0
0
1
0
Period 2
STARTED
17
17
17
16
16
17
Period 2
COMPLETED
17
17
17
16
16
17
Period 2
NOT COMPLETED
0
0
0
0
0
0
Period 3
STARTED
17
17
17
16
16
17
Period 3
COMPLETED
17
17
17
16
16
17
Period 3
NOT COMPLETED
0
0
0
0
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Test1/Test2/Control
Subjects that received Test lens 1 during the first period, Test lens 2 during the second period and the Control lens during the third period.
Test1/Control/Test2
Subjects that received Test lens 1 during the first period, the Control lens during the second period and Test lens 2 during the third period.
Test2/Test1/Control
Subjects that received Test lens 2 during the first period, Test lens 1 during the second period and the Control lens during the third period.
Test2/Control/Test1
Subjects that received Test lens 2 during the first period, the Control lens during the second and the Test 1 lens during the third period.
Control/Test1/Test2
Subjects that received the Control lens during the first period, Test lens 1 during the second period and Test lens 2 during the third period.
Control/Test2/Test1
Subjects that received the Control lens during the first period, Test 2 lens during the second period and Test lens 1 during the third period.
Period 1
Withdrawal by Subject
0
0
0
0
1
0

Baseline Characteristics

Clinical Evaluation of Investigational Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dispensed Subjects
n=101 Participants
All subjects that were dispensed at least one study lens.
Age, Continuous
32.43 Years
STANDARD_DEVIATION 9.768 • n=99 Participants
Sex: Female, Male
Female
56 Participants
n=99 Participants
Sex: Female, Male
Male
45 Participants
n=99 Participants
Race/Ethnicity, Customized
Asian
101 Participants
n=99 Participants
Region of Enrollment
China
101 Participants
n=99 Participants

PRIMARY outcome

Timeframe: 30 Minutes Post Insertion

Population: Subjects that completed all study visits without a major protocol deviation.

CLUE Handling is assessed using the Contact Lens User Experience (CLUE™) Questionnaire. CLUE™ is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact lens-wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable / positive response. 97% of the scores fall within 0 and 120 (mean +/- 3XSD).

Outcome measures

Outcome measures
Measure
Test1
n=99 Participants
Subjects that wore the Test 1 lens during any of the 3 study periods.
Test 2
n=99 Participants
Subjects that wore the Test 2 lens during any of the 3 study periods.
Control
n=99 Participants
Subjects that wore the control lens during any of the 3 study periods.
CLUE Handling
55.73 Units on a scale
Standard Deviation 20.146
57.58 Units on a scale
Standard Deviation 20.109
64.39 Units on a scale
Standard Deviation 19.825

PRIMARY outcome

Timeframe: 30 Minutes Post Insertion

Population: Subjects that completed all study visits without a major protocol deviation.

Distance time controlled Visual Performance (LogMAR) was assessed for each subject eye under bright-illumination high-contrast lighting conditions at 4m using an ETDRS chart. The average visual performance (LogMAR) was reported for each study lens.

Outcome measures

Outcome measures
Measure
Test1
n=198 Eyes
Subjects that wore the Test 1 lens during any of the 3 study periods.
Test 2
n=198 Eyes
Subjects that wore the Test 2 lens during any of the 3 study periods.
Control
n=198 Eyes
Subjects that wore the control lens during any of the 3 study periods.
Visual Performance (LogMar)
0.00 LogMAR
Standard Deviation 0.082
0.00 LogMAR
Standard Deviation 0.082
0.01 LogMAR
Standard Deviation 0.082

PRIMARY outcome

Timeframe: 30 Minutes Post Insertion

Population: Subjects that completed all study visits without a major protocol deviation.

Mechanical lens fit will be assessed for each subject and eye using a slit lamp. Lens fit is a binary response and 'Yes' = Acceptable Fit and 'No' = Unacceptable Fit. Lens fit is assessed using Lens centration, limbal exposure, primary gaze movement, up-gaze movement, edge lift, lens tightness. Unacceptable fit will be declared if there is any of the following present: limbal exposure, edge lift, excessive movement in primary or up-gaze or insufficient movement in primary gaze and up-gaze. The Percentage of subject eyes with acceptable lens fit will be reported.

Outcome measures

Outcome measures
Measure
Test1
n=198 Eyes
Subjects that wore the Test 1 lens during any of the 3 study periods.
Test 2
n=198 Eyes
Subjects that wore the Test 2 lens during any of the 3 study periods.
Control
n=198 Eyes
Subjects that wore the control lens during any of the 3 study periods.
Percentage of Eyes With Acceptable Mechanical Lens Fit
95 Percentage of eyes
97 Percentage of eyes
91 Percentage of eyes

PRIMARY outcome

Timeframe: 30 Minutes Post Insertion

Population: Subjects that completed all study visits without a major protocol deviation.

Cosmetic lens fitting is assessed for each subject eye in the primary gaze position without a slit lamp. Cosmetic lens fit is a binary response and is reported as acceptable or unacceptable. The Percentage of subject eyes with acceptable cosmetic lens fitting is reported.

Outcome measures

Outcome measures
Measure
Test1
n=198 Eyes
Subjects that wore the Test 1 lens during any of the 3 study periods.
Test 2
n=198 Eyes
Subjects that wore the Test 2 lens during any of the 3 study periods.
Control
n=198 Eyes
Subjects that wore the control lens during any of the 3 study periods.
Percentage of Eyes With Acceptable Cosmetic Lens Fit
99.5 Percentage of eyes
99.5 Percentage of eyes
99.5 Percentage of eyes

Adverse Events

Test1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Test2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Meredith Bishop, OD, MS, FAAO

Johnson & Johnson Vision

Phone: 904-443-1396

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60